[1] Hayashi PH, Lucena MI, et al. A revised electronic version of RUCAM for the diagnosis of drug induced liver injury. Hepatology,2022,76:18-31. [2] Teschke R, Danan G. Worldwide use of RUCAM for causality assessment in 81,856 idiosyncratic DILI and 14,029 HILI cases published 1993-mid 2020: a comprehensive analysis. Medicines,2020,7:62. [3] Benichou C, Danan G, Flahault A. Causality assessment of adverse reactions to drugs. II: An original model for validation of drug causality assessment methods: case reports with positive rechallenge. J Clin Epidemiol,1993,46:1331-1336. [4] Björnsson ES, Hoofnagle JH. Categorization of drugs implicated in causing liver injury: critical assessment based on published case reports. Hepatology,2016,63:590-603. [5] Ke L, Lu C, Shen R, et al. Knowledge mapping of drug-induced liver injury: a scientometric investigation (2010-2019). Front Pharmacol,2020,11:842. |